Rehmannioside A inhibits the activity of CYP3A4, 2C9 and 2D6 in vitro

Xenobiotica. 2024 Apr;54(4):195-200. doi: 10.1080/00498254.2024.2321969. Epub 2024 Mar 4.

Abstract

To assess the effect of Rehmannioside A on CYP450s activity and to estimate its inhibitory properties.The effect of Rehmannioside A on the activity of major CYP450s in human liver microsomes (HLMs) was assessed with the corresponding substrates and marker reactions, and compared with a blank control and the respective inhibitors. Suppression of CYP3A4, 2C9 and 2D6 was assessed by the dose-dependent assay and fitted with non-competitive or competitive inhibition models. The inhibition of CYP3A4 was determined in a time-dependent manner.Rehmannioside A suppressed the activity of CYP3A4, 2C9, and 2D6 with IC50 values of 10.08, 12.62, and 16.43 μM, respectively. Suppression of CYP3A4 was fitted to a non-competitive model with Ki value of 5.08 μM, whereas CYP2C9 and 2D6 were fitted to a competitive model with Ki values of 6.25 and 8.14 μM. Additionally, the inhibitory effect on CYP3A4 was time-dependent with KI value of 8.47 μM-1 and a Kinact of 0.048 min-1.In vitro suppression of CYP3A, 2C9 and 2D6 by Rehmannioside A indicated that Rehmannioside A or its source herbs may interact with drugs metabolised by these CYP450s, which could guide the clinical application.

Keywords: CYP450s; Rehmannioside A; competitive inhibition; non-competitive inhibition.

MeSH terms

  • Cytochrome P-450 CYP2C9 / metabolism
  • Cytochrome P-450 CYP2D6 / metabolism
  • Cytochrome P-450 CYP3A Inhibitors / pharmacology
  • Cytochrome P-450 CYP3A* / metabolism
  • Cytochrome P-450 Enzyme Inhibitors / pharmacology
  • Humans
  • Microsomes, Liver* / drug effects
  • Microsomes, Liver* / metabolism

Substances

  • Cytochrome P-450 CYP3A
  • Cytochrome P-450 CYP2C9
  • Cytochrome P-450 CYP3A Inhibitors
  • Cytochrome P-450 CYP2D6
  • CYP3A4 protein, human
  • Cytochrome P-450 Enzyme Inhibitors